GSK intends to sell its remaining stake in Haleon
British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off ...
Tag: Johnson & Johnson
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, ...
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) ...
Legendary value investor’s firm launches new fund targeting ‘quality’ stocks
Legendary value investor Jeremy Grantham is betting on a special caliber of stocks with his firm's first active ETF: the ...
Birkenstock expects to prices IPO at $46 per share, toward midpoint of stated range
Birkenstock models stand in a retail store of the shoe manufacturer. The company plans to go public in New York. Sebastian ...
Federal judge declines to block Medicare drug price negotiations
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January ...
Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time
In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San ...
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
Kenvue, a unit of Johnson & Johnson's consumer health business.CFOTO | Future Publishing | Getty ImagesJohnson & Johnson on Monday ...
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson's consumer-health business, speaks during an interview to celebrate its IPO ...
